A multicenter phase II study of bevacizumab (B) and temsirolimus (T) in women with recurrent epithelial ovarian cancer (OC): A study of the Mayo, Chicago, California, New York, Southeast, and Princess Margaret Phase II Consortia Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Morgan, Robert
  • Oza, Amit M
  • Qin, Rui
  • Fruth, Briant
  • Hirte, Holger
  • Mackay, Helen
  • Tsoref, Daliah
  • Strevel, Elizabeth Laureen
  • Welch, Stephen
  • Sullivan, Daniel
  • Wenham, Robert M
  • Fleming, Gini F
  • Brewer, Molly
  • Chen, Helen X
  • Doyle, L Austin
  • Gandara, David R
  • Sparano, Joseph A
  • Einstein, Mark H
  • Erlichman, Charles

publication date

  • May 20, 2013